<p>Tobias Derfuss discusses his rapid review on advances in oral immunomodulating therapies in relapsing multiple sclerosis.</p>

Tobias Derfuss discusses his rapid review on advances in oral immunomodulating therapies in relapsing multiple sclerosis.

Oral immunomodulating therapies in relapsing MS

The Lancet Neurology is a monthly journal, renowned for the publication of high-quality peer-reviewed research, reviews, and analysis from around the world. In the monthly podcasts, editors of the journal discuss highlights of the current issue, with occasional interviews with an author of a key article.

Share Oral immunomodulating therapies in relapsing MS

Sign up to save your podcasts

Oral immunomodulating therapies in relapsing MS

Oral immunomodulating therapies in relapsing MS